Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Features

Cardiac Transplant in Midst of ‘Revolution,’ but Public Trust Is Fragile

Michael O'Riordan

October 17, 2025

News Daily News

Some Mitral TEER Patients Slipping Through the Cracks in the First Month

Michael O'Riordan

March 21, 2025

News Conference News NY Valves 2024

Polymer Mitral Valve Shows Well Early, but Long-term Data Key

Michael O'Riordan

June 12, 2024

News Conference News ESC Heart Failure 2024

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

Michael O'Riordan

May 13, 2024

News Daily News

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

Michael O'Riordan

May 06, 2024

News Conference News ACC 2024

Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF

Michael O'Riordan

April 06, 2024

News Daily News

Poor Outcomes in HF Patients With Moderate Aortic Stenosis: Observational Data

Michael O'Riordan

March 29, 2023

News Conference News ESC 2022

PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2

Michael O'Riordan

August 27, 2022

News Daily News

Minimalist Valve-in-Valve TMVR as Safe as Conventional Approach

Michael O'Riordan

June 21, 2022

News Conference News THT 2022

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

Caitlin E. Cox

February 02, 2022

News Daily News

Cardiogenic Shock Teams May Lower Mortality in Cardiac ICUs

Todd Neale

September 21, 2021

News Daily News

ViV TAVR Beats Redo SAVR for Short- but Not Long-term Outcomes

L.A. McKeown

July 27, 2020

News Conference News STS 2020

PE for Surgeons: Be Active Participants in Team-Based Care, Experts Urge

Yael L. Maxwell

February 03, 2020

News Daily News

Echo Parameters Identify At-Risk Asymptomatic Patients With Severe AS

Michael O'Riordan

October 03, 2018

News Conference News The Structural Heart Disease Summit 2018

Hybrid Surgical/Interventional LV Reconstruction Improves Ejection Fraction and Patient Symptoms

Michael O'Riordan

June 27, 2018

News Daily News

FDA: Class I Recall for Cardiosave Hybrid IABP Due to ‘Fluid Ingress’

Caitlin E. Cox

June 07, 2018

News Conference News CRT 2018

Is COAPT Designed to Fail? Experts Debate Treatment Timing in Severe Functional MR

Michael O'Riordan

March 05, 2018

Advertisement

Cardiac Transplant in Midst of ‘Revolution,’ but Public Trust Is Fragile

Some Mitral TEER Patients Slipping Through the Cracks in the First Month

Polymer Mitral Valve Shows Well Early, but Long-term Data Key

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF

Poor Outcomes in HF Patients With Moderate Aortic Stenosis: Observational Data

PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2

Minimalist Valve-in-Valve TMVR as Safe as Conventional Approach

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

Cardiogenic Shock Teams May Lower Mortality in Cardiac ICUs

ViV TAVR Beats Redo SAVR for Short- but Not Long-term Outcomes

PE for Surgeons: Be Active Participants in Team-Based Care, Experts Urge

Echo Parameters Identify At-Risk Asymptomatic Patients With Severe AS

Hybrid Surgical/Interventional LV Reconstruction Improves Ejection Fraction and Patient Symptoms

FDA: Class I Recall for Cardiosave Hybrid IABP Due to ‘Fluid Ingress’

Is COAPT Designed to Fail? Experts Debate Treatment Timing in Severe Functional MR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content